Search

everythinglearnresearchcommunity

for

Search:↓

Sodium hypochlorite can effectively prevent and remove Staphylococcus aureus biofilms in atopic dermatitis at high enough concentrations.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Aminopterin strongly suppresses epithelial tissues and can treat certain skin conditions but has significant side effects.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

*Acorus calamus* has many medicinal benefits but needs more safety research.

The S100A4 protein is more common in psoriatic skin and could be a target for treating psoriasis.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Dermoscopy helps diagnose unusual skin lesions like osteonevus of Nanta and can prevent misdiagnosis of serious conditions.

A specific type of skin cell creates an opening for hair to grow out, and problems with this process can lead to skin conditions.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Belimumab effectively controls SLE disease activity and reduces steroid use.

A small forehead lesion led to the discovery of a significant brain arteriovenous malformation in a young girl.

Finasteride increases risk of sleep apnea and insomnia.

Cocaine possibly mixed with levamisole caused a woman's skin condition and blood issues, which improved with treatment.

Oral cyclosporin doesn't stop hair loss.

A standardized consent form for PRP injections improves patient trust and legal protection.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Tofacitinib helped regrow hair in most patients with severe hair loss.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

HSD11b1 affects skin nerves and increases non-histaminergic itch.